Sort
64,565 grants matching “drug discovery”
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation
$1,024,309Robert S Langer · Massachusetts Institute Of Technology · R01 · FY2018 · EB
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$1,024,222Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2019 · AI
Pacific Northwest Advanced Compound Identification Core
$1,024,120Thomas O Metz · Battelle Pacific Northwest Laboratories · U2C · FY2020 · ES
SBIR Phase II: High-Throughput Specific Cell Loading by Optoinjection
$1,024,000Glenn Sasaki · Cyntellect, Inc · · FY2003 · TIP
Inhibition of Malaria Chloroquine Resistance Transporters
$1,023,775M.g. Finn · Scripps Research Institute, The · R56 · FY2010 · AI
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$1,023,733Jin Wang · Baylor College Of Medicine · U01 · FY2023 · AG
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center
$1,023,664Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA
Resource for Structure-based Computational Drug Discovery and Design (RSD3)
$1,023,253Stefano Forli · Scripps Research Institute, The · R24 · FY2023 · GM
First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development
$1,023,231Rajesh Krishnan · Oncternal Therapeutics, Inc. · R44 · FY2022 · CA
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
$1,023,150Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R35 · FY2024 · CA
Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises
$1,022,908David A Pearlman · Quantum Simulation Technologies, Inc. · R44 · FY2024 · GM
Targeting tau for the development of novel Alzheimer's disease therapeutics
$1,022,579Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2021 · AG
Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer
$1,022,522Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2025 · CA
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
$1,022,514Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2021 · AI
Core B Medicinal Chemistry
$1,022,482Joel Stephen Freundlich · Hackensack University Medical Center · U19 · FY2019 · AI
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,022,419Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Northeast Node of the National Drug Abuse Clinical Trials Network
$1,022,375Lisa A Marsch · Dartmouth College · UG1 · FY2020 · DA
RNAi Screening in Hematopoietic Cells
$1,022,358Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
BIOTECHNOLOGY RESOURCE DIGITAL ELECTROOPTICAL IMAGING
$1,022,246Cornell University Ithaca · P41 · FY2001 · RR
Novel Small-Molecule Therapies for CF
$1,021,850Alan S Verkman · University Of California, San Francisco · P30 · FY2016 · DK
Functionally Validated Lentiviral siRNA libraries
$1,021,240Alex Chenchik · Cellecta, Inc. · R44 · FY2011 · RR
IGF::OT::IGF Medication Discovery Using Rat Models of Relapse; POP 8/29/2014-7/9/2017; FY16 N01DA-14-8917
$1,021,163Patrick Beardsley · Virginia Commonwealth University · N01 · FY2016 · DA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,021,151Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Identification of novel MDR antimicrobials from symbioses between terrestrial and marine invertebrates and rare microbial taxa
$1,020,785Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2020 · AI
DISCOVERY OF NOVEL DRUGS FOR ALZHEIMERS DISEASE
$1,020,676University Of Florida · P01 · FY2002 · AG